CERo Therapeutics Holdings, Inc.
CERO
$0.09
$0.0113.64%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.86% | -121.23% | -122.02% | 153.11% | -183.07% |
| Total Depreciation and Amortization | -8.24% | -8.73% | -6.49% | -0.07% | 5.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.17% | 145.47% | 121.32% | -2,593.39% | 264.67% |
| Change in Net Operating Assets | -42.78% | -163.11% | 92.22% | 1,051.96% | 2,081.88% |
| Cash from Operations | -16.19% | -30.70% | 12.49% | -60.29% | -109.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -348.30% | -266.26% |
| Issuance of Common Stock | -- | -- | -0.77% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 124.96% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 59.83% | -- | -- | 5,023.90% | -1,107.89% |
| Cash from Financing | -42.83% | 5.06% | -11.68% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -379.99% | -100.92% | -9.68% | 94.47% | 79.76% |